^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    PANAMutyper™ R KRAS

    Company:
    Panagene
    Type:
    CE Marked
    Related tests:
    Details
    Evidence

    News

    almost5years
    Comparison of PANAMutyper and PNAClamp for Detecting KRAS Mutations from Patients With Malignant Pleural Effusion. (PubMed, In Vivo)
    "PANAMutyper™ had a diagnostic superiority for the detection of KRAS mutations in patients with malignant pleural effusion compared to PNAClamp™, although there was a concordance between PANAMutyper™ and PNAClamp™ results. Therefore, PANAMutyper™ can be used for a more sensitive and accurate detection of KRAS mutations."
    Journal • Clinical
    |
    PANAMutyper™ R KRAS